Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Exo Therapeutics is a small molecule drug discovery and development company.
A private biopharmaceutical company .
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
Flame Biosciences is a clinical-stage company focused on therapies for cancer and other inflammatory diseases.
Rain Oncology is a operator of a clinical stage biotechnology company.
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
Velicept Therapeutics is a privately held clinical development
Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 11 different industry categories.
Among tracked funding rounds, Science 37 received $200.0M in a Post Ipo Equity round. Samsara BioCapital's total known invested capital is $12.1B.
Samsara BioCapital's average investment size is $113.4M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include SanReno Therapeutics, Ablaze Pharmaceuticals, Science 37, Exo Therapeutics, Neurogastrx. These companies were founded in 2020 or later.